I have a question about a wellness ABN. Do you have to specify for repetitive or continuous noncovered care the frequency and/or duration of the item or service in the Blank D area (box in the middle of form). I have heard from other sources that Blank D (Services) box should look like (example) 24 CMT visits/1year. I was not doing them this way but another consultant group pointed out that it is in the instructions. Is this right?
To answer that question, let's look at the official instructions with emphasis added. It's like the non-participating provider instructions to strikeout certain text. There is some ambiguity which leaves the door open for some interpretation.
"The notifier must list the specific items or services believed to be noncovered under the header of Blank (D).
In the case of partial denials, notifiers must list in Blank (D) the excess component(s) of the item or service for which denial is expected.
For repetitive or continuous noncovered care, notifiers must specify the frequency and/or duration of the item or service. See § 50.14.3 for additional information.
Section 50.14.3 states the following:
"50.14.3 - Repetitive or Continuous Noncovered Care (Rev.1587, Issued: 09-05-08, Effective: 03-03-08, Implementation: 03-01-09) Notifiers may give a beneficiary a single ABN describing an extended or repetitive course of noncovered treatment provided that the ABN lists all items and services that the notifier believes Medicare will not cover. If applicable, the ABN must also specify the duration of the period of treatment. If during the course of treatment additional noncovered items or services are needed, the notifier must give the beneficiary another ABN. The limit for use of a single ABN for an extended course of treatment is one year. A new ABN is required when the specified treatment extends beyond one year."
Notice the "if applicable" used in conjunction with the "must". Because CMT is a covered benefit which is not always payable (i.e., maintenance care) it comes down to semantics. So go ahead and state the duration and frequency, but we recommend being a little more vague and saying "up to" or "approximately" before listing a number of visits per year (e.g., up to 24 visits/12 months).
If you have questions or comments about this article please contact us. Comments that provide additional related information may be added here by our Editors.
To determine the dosage, size, doses per package and how many billing units are in each package, refer to the NDC number.
Take a look at the following
J1071 - Injection, testosterone cypionate, 1mg
For example; using NCD # 0009-0085-10 there are 10 doses of 100 mL
(100 mg/mL = 1 mL and there are ...
As we begin returning back to work, we will all face a new normal. The COVID-19 pandemic has changed the face of business. While it has certainly been a challenge to keep up with the ever-changing regulations (that’s likely to continue for a little longer), exciting new opportunities have also been created, such as the expansion of telemedicine. There’s also the maze of government funding that needs to be navigated and an increased awareness of OSHA standards to implement.
The CDC has released additional information and coding guidance for reporting encounters related to the 2019 health care encounters and deaths related to e-cigarette, or vaping, product use associated lung injury (EVALI).
The update offers coding scenarios for general guidance, poisoning and toxicity, substance abuse and signs and symptoms.
ICD-10-CM Official Coding Guidelines - ...
On April 30, 2020, CMS announced additional sweeping changes to meet the challenges of providing adequate healthcare during this pandemic. These changes expand the March 31st changes. The article covers some of the key changes. See the official announcement in the references below.
Risk adjustment is simply a way of making sure that there are sufficient funds to adequately take care of the healthcare needs of a certain population. It’s a predictive modeling methodology based on the diagnoses of the individuals in that population. As payers move to value based models, they heavily rely on risk adjustment to ensure proper funding.
All healthcare providers who are currently participating in the MIPS portion of Medicare’s Quality Payment Program may want to participate in the new COVID-19 Clinical Trials improvement activity. Read more about it here.
With all the new laboratory test codes that have been added due to the current public health emergency (PHE), there are a few additional guidelines CMS has released about collecting samples to perform the testing. Please keep in mind that these guidelines are by CMS and may or may not apply to other commercial payer policies.